A. Rios

发表

Application of Deep Learning in Predicting the Prognosis of Acute Myeloid Leukemia using Cytogenetics, Age, and Mutations

Hanadi El Achi, A. Nguyen, Z. Hu, 2020, Clinical Oncology and Research.

HER3/ErbB3, an emerging cancer therapeutic target.

Ningyan Zhang, Z. An, A. Rios, 2015, Acta biochimica et biophysica Sinica.

Human endotrophin as a driver of malignant tumor growth.

P. Lønning, P. Scherer, Jiyoung Park, 2019, JCI insight.

Dramatic response of nivolumab-associated psoriasiform dermatitis to etoposide.

Anisha B. Patel, P. Cen, S. Mays, 2019, European journal of cancer.

Expression of Sirt1 and FoxP3 in classical Hodgkin lymphoma and tumor infiltrating lymphocytes: Implications for immune dysregulation, prognosis and potential therapeutic targeting.

Robert E. Brown, Rongzhen Zhang, N. Nguyen, 2015, International journal of clinical and experimental pathology.

Durable remission with Bruton’s tyrosine kinase inhibitor therapy in a patient with leptomeningeal disease secondary to relapsed mantle cell lymphoma

A. Rios, B. Yohannan, A. Sridhar, 2022, BMJ Case Reports.

Morphoproteomics identifies constitutive activation of the mTORC2/Akt and NF-κB pathways and expressions of IGF-1R, Sirt1, COX-2, and FASN in peripheral T-cell lymphomas: pathogenetic implications and therapeutic options.

Robert E. Brown, N. Nguyen, Andrés E Quesada, 2014, International journal of clinical and experimental pathology.

Mixed-Phenotype Acute Leukemia: Clinical Diagnosis and Therapeutic Strategies

Anneliese O. Gonzalez, A. Rios, Binsah George, 2022, Biomedicines.

Expression of constitutively activated NF-κB/mTORC pathway proteins and response to CHOP with bortezomib in a patient with angioimmunoblastic peripheral T-cell lymphoma.

Robert E. Brown, N. Nguyen, Andrés E Quesada, 2014, Clinical lymphoma, myeloma & leukemia.

Durable Remission in Hodgkin Lymphoma Treated With One Cycle of Bleomycin, Vinblastine, Dacarbazine and Two Doses of Nivolumab and Brentuximab Vedotin

A. Rios, B. Yohannan, M. Buja, 2022, Journal of hematology.

Complete inactivation of HIV-1 using photo-labeled non-nucleoside reverse transcriptase inhibitors.

M. Wainberg, J. Quesada, S. Colby-Germinario, 2011, Virus research.

HIV-1 p17 synthetic peptide vaccine HGP-30: induction of immune response in human subjects and preliminary evidence of protection against HIV challenge in SCID mice.

J. Kahn, B. Gazzard, M. Youle, 1995, Cellular and molecular biology.

Didanosine Compared with Continuation of Zidovudine in HIV-infected Patients with Signs of Clinical Deterioration While Receiving Zidovudine

A. Cross, D. Peterson, I. Frank, 1994, Annals of Internal Medicine.

Kaposi sarcoma: a fresh look.

A. Rios, 2021, AIDS.

Primary Effusion Lymphoma: A Clinicopathological Study of 70 Cases

Zenggang Pan, L. Medeiros, Endi Wang, 2021, Cancers.

A. Rios, 2014, Clinical lymphoma, myeloma & leukemia.

A. Rios, 2022 .

Antibody therapies for the treatment of acute myeloid leukemia: exploring current and emerging therapeutic targets

N. Daver, C. Dinardo, C. Zhang, 2023, Expert opinion on investigational drugs.

TP53 in Acute Myeloid Leukemia: Molecular Aspects and Patterns of Mutation

Natalia Baran, H. Kantarjian, A. Rios, 2021, International journal of molecular sciences.

Fundamental challenges to the development of a preventive HIV vaccine.

A. Rios, 2018, Current opinion in virology.

HIV inactivation: time for a second look.

Dallas W. Anderson, Q. Yao, E. Poteet, 2015, AIDS.

Synchronous Presentation of Autoimmune Hepatitis and Multiple Myeloma

V. Tammisetti, A. Rios, B. Yohannan, 2022, Journal of hematology.

Old and New Concepts and Strategies in HIV Vaccinology: A Report froma Workshop held in Rome on 17 June 2016

Felipe García, M. Amicosante, B. Ensoli, 2016 .

Acute myeloid leukemia with mutated NPM1 mimics acute promyelocytic leukemia presentation

A. Wahed, N. Nguyen, Manuel J Arana Rosainz, 2020, International journal of laboratory hematology.

Inside the Biology of Acute Leukemias of Ambiguous Lineage: Diagnostic Work-Up, Genomic and Clinical Characterization

A. Rios, Binsah S George, Anneliese Gonzalez, 2022, Journal of Cancer Science and Clinical Therapeutics.

Complete and repeatable inactivation of HIV-1 viral particles in suspension using a photo-labeled non-nucleoside reverse transcriptase inhibitor.

C. Marin-Muller, E. Siwak, D. Anderson, 2013, Journal of virological methods.

HIV inactivation by cross-linking of photo-labeled anti-retroviral compounds with HIV reverse transcriptase.

M. Wainberg, J. Quesada, S. Colby-Germinario, 2009, Vaccine.

T-Cell Prolymphocytic Leukemia With t(X;14)(q28;q11.2): A Clinicopathologic Study of 15 Cases.

L. Medeiros, Lina Shao, Z. Hu, 2023, American journal of clinical pathology.

Application of Deep Learning on Predicting Prognosis of Acute Myeloid Leukemia with Cytogenetics, Age, and Mutations pdf

Lei Chen, Mei Lin, Zhihong Hu, 2018, ArXiv.

The use of modern imaging technologies in radiation therapy of cervical cancer

Angel I. Blanco, B. Teh, A. Blanco, 2015, Journal of Radiation Oncology.

The 2018 Nobel Prize in Medicine for breakthroughs in targeting immune checkpoint inhibitors: a brief perspective

Georgina T Salazar, Ningyan Zhang, Z. An, 2019, Antibody therapeutics.

Automated Diagnosis of Lymphoma with Digital Pathology Images Using Deep Learning

Lei Chen, Zhihong Hu, Amer Wahed, 2018, Annals of clinical and laboratory science.

MCL-247: Durable Response of a Patient with a Mantle Cell Lymphoma Central Nervous System (CNS) Relapse to Treatment with a Bruton Tyrosine Kinase Inhibitor (BTKi) Monotherapy

A. Wahed, N. Nguyen, B. Dinh, 2020 .

REMISSION OF AIDS-ASSOCIATED PSORIASIS WITH ZIDOVUDINE

M. Duvic, A. Rios, G. Brewton, 1987, The Lancet.

Primary Diffuse Large B-Cell Lymphoma of the Bone

A. Rios, B. Yohannan, 2023, Journal of hematology.

Durable response of glioblastoma to adjuvant therapy consisting of temozolomide and a weekly dose of AMD3100 (plerixafor), a CXCR4 inhibitor, together with lapatinib, metformin and niacinamide

Mary F. McGuire, Robert E. Brown, A. Day, 2016, Oncoscience.

Morphoproteomics Identifies Etiopathogenetic Correlates of HHV-8-Associated Kaposi's Sarcoma and Provides Pathways with Therapeutic Options: A Case Study.

Robert E. Brown, A. Rios, J. Buryanek, 2016, Annals of clinical and laboratory science.

Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group.

S. Stewart, B. Dezube, D. Aboulafia, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

AML-173 Pseudotumor Cerebri (PTC) in Patients With Acute Leukemia (AL).

A. Rios, B. Yohannan, F. Cervoni-Curet, 2022, Clinical Lymphoma, Myeloma & Leukemia.

Primary Diffuse Large B-Cell Lymphoma of the Bone

A. Rios, B. Yohannan, 2023, Journal of hematology.

Reduced-Intensity Anthracycline-Free Chemoimmunotherapy in Elderly Patients With Newly Diagnosed or Relapsed Diffuse Large B-Cell Lymphoma

A. Rios, B. Yohannan, 2023, Journal of hematology.

Variable expression of CXCR4 in molecular subtypes of infiltrating gliomas.

Takeshi Takayasu, M. Quezado, L. Ballester, 2020, Clinical neuropathology.